Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples